Diego A Pizzagalli is an expert in Psychiatry at McLean Hospital (United States). As of October 2026, ScienceLeadR ranks Diego A Pizzagalli in the top 1% of experts worldwide for depressive disorder, major. Diego A Pizzagalli has authored 539 publications, the most recent in 2026, and is an investigator in 27 clinical trials. SLR score: 3,465 (community average: 125). How the SLR is computed.

LeadR Profile

Diego A Pizzagalli McLean Hospital United States
3 465 ScienceLeadR Reputation 3465
Network Map

Psychiatry

Subspecialties: Neurology - Psychology - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Harvard University

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Correction: Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression.
PMID 42897265 — depression, molecular biology, mental disorders, neurosciences, therapeutics, depressive disorder, treatment-resistant
Mol Psychiatry20260
Brain-wide reconfiguration of burst firing by psilocybin reveals 5-HT2A-dependent circuit dynamics.
PMID 42818490 — brain, psilocybin, ketanserin, fires
bioRxiv20261
Alignment of natural language processing-derived RDoC scores with depression, anhedonia, and anxiety in psychiatric electronic health records.
PMID 42816530 — depression, psychopathology, natural language processing, language, anhedonia, electronic health records, records, psychometrics, generalized anxiety disorder
NPP Digit Psychiatry Neurosci20260
Nociceptin orphanin F/Q Pathways are dysregulated by stress and modulate reward responsiveness and motivated behavior across species.
PMID 42763342 — molecular biology, mental disorders, stress, physiological, phenotype, reward, neurosciences, sex, learning
Mol Psychiatry20260
Acute effects of AT 1 receptor blockade on approach-avoidance of negative emotional faces.
PMID 42745010 — depression, bias, losartan, reward, angiotensins, therapeutics
Neuropsychopharmacology20260

Clinical Studies 27

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 12

By phase:

N/A 14
Phase 4 5
Phase 1 4
Phase 2 3
Early Phase 1 1

By status:

Completed 24
Terminated 2
Active not recruiting 1

By type:

Interventional 19
Observational 8

By Monocentric/Multicentric:

monocentric 17
multicentric2to4 8
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map